Rydex Series Trust Nova Fund

3 / 5 Stars
3 4 2 5 2
Zacks Investment Research
3 (Hold)
Standard & Poor's
4 / 5 Stars
B+ (Buy)

#8 in Trading-Leveraged Equity

U.S. News evaluated 45 Trading-Leveraged Equity Funds. Our list highlights the top-rated funds for long-term investors based on the ratings of leading fund industry researchers.

See all Rydex Funds funds

See full Trading-Leveraged Equity rankings

See more fund rankings


The fund has returned 36.13 percent over the past year, 22.47 percent over the past three years, 26.17 percent over the past five years, and 7.39 percent over the past decade.

Trailing Returns Updated 06.30.2014
Year to date 9.7%
1 Year 36.1%
3 Years (Annualized) 22.5%
5 Years (Annualized) 26.2%
10 Years (Annualized) 7.4%

See more RYANX performance


The investment seeks to provide investment results that match, before fees and expenses, 150% of the performance of the S&P 500® Index on a daily basis. The fund employs as its investment strategy a program of investing in the common stock of companies that are generally within the capitalization range of the underlying index and leveraged derivative instruments, which primarily consist of equity index swap agreements, futures contracts, and options on securities, futures contracts, and stock indices. It may hold U.S. government securities or cash equivalents to collateralize its derivative positions. The fund is non-diversified.


Fees are Above Average compared to funds in the same category.
Rydex Series Trust Nova Fund has an expense ratio of 1.53 percent.

See more RYANX fees


Risk is High compared to funds in the same category according to Morningstar.

See more RYANX risk